TcrossGlobal

Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients with DES Undergoing Low-to-intermediate Risk Non-cardiac Surgery: The ASSURE DES Randomized Clinical Trial

The ASSURE DES trial demonstrated that, in patients undergoing non-cardiac surgery more than one year after DES implantation for PCI, a strategy of continuing aspirin monotherapy during the perioperative period did not significantly reduce 30-day ischemic events and increased minor bleeding compared with a strategy of temporarily discontinuing all antiplatelet therapy (for 5 days), according to a study presented by Dr. Jung-Min Ahn of Asan Medical Center, Korea, in the Hot Line session at ESC Congress 2024.

The current guidelines recommend continuing aspirin during the perioperative period for patients und...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.